NMT200 Midterm Flashcards
(94 cards)
goals of therapy in obesity
- overall, aim to reduce body fat for health by 5-10% for health benefits
- stabilize and prevent further weight gain
- prevent weight regain
- prevent and treat obesity-related comorbidities/complications
drugs associated with weight gain
- antidepressants (particularly tricyclic antidepressants)
- antipsychotics - first and second generations
- corticosteroids (ex. prednisone)
- antihyperglycemic drugs (sulfonylureas, meglitinides, thiazolidinediones); insulin
- lithium
which drugs are most likely to cause the greatest increase in weight gain
insulin
antipsychotics
lithium
T/F: lifestyle modification alone is superior to lifestyle modification and anti-obesity therapy
false: lifestyle modification and anti-obesity therapy together is superior
drugs that fall into the appetite suppressant category
bupropion alone
bupropion in combination with naltrexone
what other indications are there for bupropion?
antidepressant
smoking cessation aid
alcohol abuse disorder
indication for bupropion/naltrexone combination
indicated for weight management alongside diet and exercise for those with BMI of 30 or higher (27 if weight-related comorbidity present)
- mediates hormones involved in appetite and reward
what are the other indications for naltrexone
anti-opioid medication
adverse effects of bupropion
dry mouth, constipation, agitation, insomnia, anxiety
higher doses: seizures (rare)
hepatic impairment (fibrotic changes)
adverse effects for bupropion/naltrexone combination
contraindications
n/v, constipation, headache, dizziness, insomnia, dry mouth
contrindicated with concurrent opioid therapy due to precipitation of opioid withdrawal - patients must be opioid free for 7 days prior to initiation of treatment
avoid using bupropion with:
avoid concurrent use of drugs that lower seizure threshold
minimize/avoid alcohol
consuming with high-fat meal
uncontrolled hypertension, seizure disorder, severe hepatic impairment, end-stage renal failure
what drug for obesity falls into the class of lipase inhibitors?
orlistat
orlistat mechanism of action
gastric and pancreatic lipase inhibitor that reduced dietary fat absorption by 30%
orlistat adverse effects
contraindications
oily spotting, flatus with discharge, fecal urgency
decreased absorption of fat-soluble vitamins
contraindicated: chronic malabsorption syndrome or cholestasis
orlistat cautions
advise to take multivitamin daily at least 2 hrs before/after orlistat/at bedtime
high fat intake is poorly tolerated
less effective in patients on low fat diets
what are the major incretin hormones in humans?
what do they have in common re: metabolism?
GLP-1 and GIP (glucose dependent insulinotropic polypeptide)
they are responsible for most of the glucose-induced insulin secretory response following ingestion of glucose
both are metabolized by the enzyme dipeptidyl peptidase 4 (DPP4)
mechanism of action for incretin mimetics
GLP-1 - reduction of food intake and appetite, increased satiety, decreased gastric emptying, and affects reward-related systems in the brain
GIP has less effect on other organs, delays gastric emptying, plays a role where fat is depositied
what class of drugs does liraglutide fit into
incretin mimetic - a GLP-1 agonist
liraglutide:
administration
indications
administered via subcutaneous injection DAILY
indicated: type 2 diabetes, weight loss
liraglutide adverse effects
most common: n/v, constipation, diarrhea
GI side effects can be minimized in slow titration of dose
can cause pancreatitis in rare instances
severe hypoglycemia in patients with T2D
cautions of taking liraglutide
- in patients with heart rhythm disturbances, hepatic insufficiency, severe renal impairment
- should not be used in IBD (slows gastric emptying)
contraindications of liraglutide
pregnancy, breastfeeding
personal or family history of medullary thyroid carcinoma or multiple neoplasia syndrome type 2 (MEN2)
when to discontinue liraglutide in obesity
after 12 weeks if body weight loss is <5%
what class of obesity drugs does semaglutide fall into?
mechanism of action?
incretin mimetics - is a GLP-1 agonist like liraglutide